Device Firms Should Get Used To Lower Growth Rates, Analyst Says
This article was originally published in The Gray Sheet
Executive Summary
Growth rates for device use declined precipitously last quarter, and the industry should be prepared for a slow recovery, say Morgan Stanley device sector analysts. What's more, pre-2009 growth rates may be out of reach in the foreseeable future
You may also be interested in...
Medtronic Q1 Revenues Fall 4% On Decreased Hospital Utilization
Medtronic is blaming a 4% decline in corporate first quarter sales on worsening hospital utilization rates in the U.S. The businesses most affected were Cardiac Rhythm Disease Management and Spine, CEO Bill Hawkins reported during an Aug. 24 earnings call
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.